Concepedia

Rebecca K. Rowntree

RK

26

Publications

1.9K

Citations

19

H-Index

2001

Active since

Affiliations

WuXi AppTec (China)(Current)

Howard Hughes Medical Institute

Harvard University

Massachusetts General Hospital

John Radcliffe Hospital

Rebecca K. Rowntree is an author at WuXi AppTec (China) specializing in medicine, natural sciences, and developmental biology.

ORCID

Top concepts

Publications per year

2001–2024

26

Publications

26

LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity

Akshay T. Krishnamurty, Justin A. Shyer, Minh Thai et al. · Nature · 2022 · 348 citations · Full text

X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells

Susana S. Silva, Rebecca K. Rowntree, Shila Mekhoubad et al. · Proceedings of the National Academy of Sciences · 2008 · 299 citations · Full text

, , +18

Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> Activity

Thomas H. Pillow, Pragya Adhikari, Robert A. Blake et al. · ChemMedChem · 2019 · 178 citations

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy

Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake et al. · Journal of Medicinal Chemistry · 2021 · 159 citations

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties

Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake et al. · Journal of Medicinal Chemistry · 2021 · 140 citations

Rows per page

1–5 of 26